ApoE, one of the major proteins associated with Alzheimer’s Disease (Serrano-Pozo et al., 2021) and represents one example of where crosstalk with a neurodegenerative disease might provide a novel approach to TBI therapeutics (Laskowitz and Van Wyck, 2023). Here, APOE is linked to early-onset autosomal dominant Alzheimer disease.